Monoclonal antibodies are among our greatest assets in treating and preventing virus-induced disease. While the spotlight has focused squarely on Covid-19 monoclonal antibodies throughout the pandemic ...

Researchers test low-cost methylene blue and blood biomarkers to detect cerebral malaria early and reduce brain injury, ...

A new anti-malaria drug with a cure rate of over 97 per cent has been developed by scientists. The drug is the first to be created in 25 years and was made in an attempt to eliminate resistance to ...

Malaria continues to place a substantial burden on many emerging economies, contributing to significant loss of life, ...

An experimental antibody treatment prevented malaria in the majority of participants in a small but important new study, providing a measure of hope in the effort to lower the burden of the disease ...

Asymptomatic malaria infections do not reduce the risk of severe disease, as widely believed, but suppress the immune system and prevent it from getting rid of parasites that persist in the ...

WEST LAFAYETTE, Ind. - The fight against one of the world's deadliest infectious diseases — malaria — may soon have two new weapons. The World Health Organization this week endorsed a vaccine, ...

The world is focused on finding a link between pregnant women infected with the Zika virus and severe birth defects. But two studies and an editorial in this week's New England Journal of Medicine are ...

Approximately one-half of the global population live in malaria-endemic regions, and it has been reported that there are 219–451 million new cases of malaria and 660,000–1,238,000 deaths owing to the ...

The latest locally aquired case of malaria in the U.S. has been identitfied in Saline County, Arkansas, according to the state's department of health. "This is the only known locally acquired case of ...

The new drug could help millions who already had the illness before. A new drug to treat malaria could help millions. The Food and Drug Administration has approved the drug Krintafel (tafenoquine) for ...

A cancer drug repurposed to treat malaria has been shown to be nearly 100% effective in helping defeat the disease in just three days, according to the results of a Phase 2 clinical trial. The results ...